Despite campaigns for regulatory reform since a corruption and fraud scandal in 2013, India’s Central Drugs Standard Control Organisation remains unreformed, and a law on drug recalls has been under discussion since 1976 without resolution. Experts call for overhaul, transparency, and accountability to ensure safer manufacturing and export practices.
